ArticleMicrobial cell factories2025
Construction and evaluation of recombinant Lactobacillus plantarum expressing Micropterus salmoides hepcidin.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- EngineeredFrontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHepcidin is an antimicrobial peptide involved in innate immunity, and the addition of hepcidin or probiotics expressing hepcidin to feed can significantly enhance the disease resistance of farmed animals. Lactobacillus plantarum has the advantages of stable colonization in the animal gut, promotion of intestinal health, and efficient expression of foreign proteins. Previously, we have used L. plantarum (LP37) as a feed additive to promote the growth of Micropterus salmoides and Oreochromis mossambicus. The aim of this study is to construct a recombinant LP37 expressing hepcidin and evaluate its role in improving antibacterial ability and growth promotion in M. salmoides.
resultsBased on the expression vector pSIP403, we used green fluorescent protein (GFP) as a reporter gene to compare the effects of four promoters on the expression levels of foreign proteins and selected the promoter TUFA with the highest expression level. By introducing the ribosomal binding site (RBS) and secretory signal peptide sequence (SP-PGH), we constructed a novel vector capable of efficiently expressing M. salmoides hepcidin (MsHep) extracellularly. Transformation of the novel vector into LP37 to obtain the recombinant strain: LP37-MsHep. This recombinant LP37-MsHep demonstrated considerable antibacterial activity against Aeromonas hydrophila and several other microbes. The dietary supplementation of recombinant LP37-MsHep for 60 days significantly enhanced the survival rates of M. salmoides and reduced tissue bacterial load in M. salmoides post infection with A. hydrophila, and regulated gene expression of FPN1, IL-10, TNF-
conclusionsCollectively, the recombinant LP37-MsHep is capable of significantly improving growth performance and disease resistance of M. salmoides, presenting it as a promising green feed additive in aquaculture with broad application potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.